The main objective of this multicenter cohort study is to determine the degree of COVID19 infection immunization of a population of psychiatric patients. The secondary objective of this cohort follow-up is to: 1. Clinically characterize COVID patients who are positive for serological testing 2. Assess the socio-demographic, clinical and psychotropic determinants of a COVID diagnosis 3. Immunologically characterize COVID patients who are positive for serological testing 4. Exploring the links between susceptibility to COVID19 and erythrocytic blood groups
All patients accepting to participate will be included in participating psychiatry services
and will have a COVID Serological Test for Inclusion with confirmation at J15 including
immune-genetics data.
A Comparison of COVID patients versus no COVID patients will be based on a clinical
examination (psychiatric, somatic) and blood samples collected at J0 and J15.
Diagnostic Test: COVID19 immunization testing
serological COVID19 test with confirmation at J15 during hospitalization
Inclusion Criteria:
- Adult patient
- Hospitalized in one of the participating psychiatric wards during the inclusion period
- Signed informed consent
Exclusion Criteria:
- Inability to obtain the consent of the patient or legal representative, if applicable
- Patient under safeguard of justice
Assistance Publique - Hôpitaux de Paris
Paris, Ile De France, France
Investigator: Isabelle Vivaldo
isabelle.vivaldo@aphp.fr
France GUYOT
0144841751 - 33
france.guyot@aphp.fr
Marion LEBOYER, PHD, Principal Investigator
Assistance Publique des Hopitaux de Paris